Brief verbal intervention to address inappropriate prescriptions of chinese patent medicines among western practitioners in primary health care (BRAVERY): a study protocol for an unannounced standardized patient experiment with a factorial design randomized controlled trial in China.

ABSTRACT:

Introduction

Chinese patent medicines, produced using advanced pharmaceutical techniques and available in various forms, including powders, granules, tablets, pills, and capsules, finds extensive utilization among Western medicine practitioners in primary healthcare (WMP-PHC). However, the inappropriate overprescribing of these medicines has led to significant resource waste and raised considerable concerns. Therefore, we aim to address related knowledge gaps by employing unannounced standardized patients (USPs) as a method, for both measurement and intervention research. Specifically, in this paper, we present a study protocol that aims to develop and evaluate the effectiveness of brief verbal interventions (BVI) delivered by USPs, with the objective of improving the appropriate p

SUBMITTER: Zhao Q 

PROVIDER: S-EPMC12020188 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature